Market Overview:
The global kainic acid market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of neurological disorders, rising demand for novel epilepsy treatments, and growing investments in neurological research. Kainic acid is used as an adjuvant therapy for the treatment of various forms of epilepsy and also finds application in neurological research. However, high toxicity levels associated with kainic acid are expected to restrain the growth of this market during the forecast period. Based on type, the global kainic acid market can be segmented into low purity (below 97%), purity (above 97% and below 99%), high purity (above 99%), and others. The high purity segment is expected to account for a major share of the global kainic acid market during the forecast period owing to its superior properties such as solubility and stability. Based on application,the global kainic acidmarket can be divided into epilepsy treatment, neurological research,and others.
Product Definition:
Kainic acid is a neurotransmitter that is released from nerve cells in the brain. It plays an important role in learning and memory.
Low Purity(Below 97%):
Kainic acid or 2-methyl4-oxopentanoic acid is a pungent, highly irritant, white crystalline compound. It's a key intermediate in the production of industrial chemicals and pharmaceuticals. Kainic acid is manufactured by the catalytic oxidation of ethylene and propylene with subsequent hydrolysis to form 2-methyl4-oxopentanoic acid (MOPA).
Purity(Above 97% and Below 99%):
Purity is the percentage of active ingredients in a given formulation. It can be considered as the most important attribute of any drug product. The purity of a drug substance should be more than 97% and less than or equal to 99%.
The major factor that affects the value of purity is route of preparation - throughout history, different methods have been used for manufacturing drugs such as crystallization, sublimation,.
Application Insights:
The epilepsy treatment segment dominated the global market in terms of revenue in 2017. This can be attributed to the rising incidence of epilepsy coupled with a high unmet medical need for effective and safe treatments. According to WHO, approximately 50 million people are living with epilepsy worldwide, which is around 2.0% of the population globally. Moreover, an estimated 1-2 new cases of infantile spasms and 0.5-1 new cases every year are being reported mainly in developing countries such as India, China and Brazil owing to lack of awareness and availability of inappropriate diagnosis facilities at an early stage coupled with improper treatment methods at a later stage thus presenting opportunities for kainic acid manufacturers during the forecast period 2018 to 2030 globally.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period owing to rising product demand from various end-use industries, such as pharmaceuticals and nutraceuticals. In addition, increasing prevalence of neurological disorders coupled with growing healthcare spending by the local governments is anticipated to drive growth during the forecast period.
The Asia Pacific was followed by Europe in terms of revenue generation due to high EpiGen Research Consortium funding for kainic acid-based research projects in 2016 across European countries such as U.K., Germany, and Switzerland that are driving regional growth through 2030 forecasted scenario.
Growth Factors:
- Increasing demand for Kainic Acid in pharmaceutical and biotechnology industries for the treatment of various neurological disorders.
- Rising research and development activities by key players to develop novel therapeutics using Kainic Acid.
- Growing number of collaborations and partnerships between key players to develop new applications for Kainic Acid.
- Increasing investments by leading players to expand their manufacturing capacities of Kainic Acid globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Kainic Acid Market Research Report
By Type
Low Purity(Below 97%), Purity(Above 97% and Below 99%), High Purity(Above 99%), Others
By Application
Epilepsy Treatment, Neurological Research, Others
By Companies
R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz Biotechnology, STEMCELL Technologies, Alfa Chemistry, Anward, Race Chemical, Glentham Life Sciences, AbMole Bioscience, Aurum Pharmatech LLC, Tocris Bioscience, Enzo Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Kainic Acid Market Report Segments:
The global Kainic Acid market is segmented on the basis of:
Types
Low Purity(Below 97%), Purity(Above 97% and Below 99%), High Purity(Above 99%), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Epilepsy Treatment, Neurological Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- R&D Systems
- Abcam
- Stemgent
- Cayman Chemical
- Santa Cruz Biotechnology
- STEMCELL Technologies
- Alfa Chemistry
- Anward
- Race Chemical
- Glentham Life Sciences
- AbMole Bioscience
- Aurum Pharmatech LLC
- Tocris Bioscience
- Enzo Life Sciences
Highlights of The Kainic Acid Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Low Purity(Below 97%)
- Purity(Above 97% and Below 99%)
- High Purity(Above 99%)
- Others
- By Application:
- Epilepsy Treatment
- Neurological Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Kainic Acid Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Kainic acid is a chemical that is found in the brain and spinal cord. It can cause seizures, hallucinations, and other problems.
Some of the key players operating in the kainic acid market are R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz Biotechnology, STEMCELL Technologies, Alfa Chemistry, Anward, Race Chemical, Glentham Life Sciences, AbMole Bioscience, Aurum Pharmatech LLC, Tocris Bioscience, Enzo Life Sciences.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Kainic Acid Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Kainic Acid Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Kainic Acid Market - Supply Chain
4.5. Global Kainic Acid Market Forecast
4.5.1. Kainic Acid Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Kainic Acid Market Size (000 Units) and Y-o-Y Growth
4.5.3. Kainic Acid Market Absolute $ Opportunity
5. Global Kainic Acid Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Kainic Acid Market Size and Volume Forecast by Type
5.3.1. Low Purity(Below 97%)
5.3.2. Purity(Above 97% and Below 99%)
5.3.3. High Purity(Above 99%)
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Kainic Acid Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Kainic Acid Market Size and Volume Forecast by Application
6.3.1. Epilepsy Treatment
6.3.2. Neurological Research
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Kainic Acid Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Kainic Acid Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Kainic Acid Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Kainic Acid Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Kainic Acid Demand Share Forecast, 2019-2026
9. North America Kainic Acid Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Kainic Acid Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Kainic Acid Market Size and Volume Forecast by Application
9.4.1. Epilepsy Treatment
9.4.2. Neurological Research
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Kainic Acid Market Size and Volume Forecast by Type
9.7.1. Low Purity(Below 97%)
9.7.2. Purity(Above 97% and Below 99%)
9.7.3. High Purity(Above 99%)
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Kainic Acid Demand Share Forecast, 2019-2026
10. Latin America Kainic Acid Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Kainic Acid Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Kainic Acid Market Size and Volume Forecast by Application
10.4.1. Epilepsy Treatment
10.4.2. Neurological Research
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Kainic Acid Market Size and Volume Forecast by Type
10.7.1. Low Purity(Below 97%)
10.7.2. Purity(Above 97% and Below 99%)
10.7.3. High Purity(Above 99%)
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Kainic Acid Demand Share Forecast, 2019-2026
11. Europe Kainic Acid Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Kainic Acid Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Kainic Acid Market Size and Volume Forecast by Application
11.4.1. Epilepsy Treatment
11.4.2. Neurological Research
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Kainic Acid Market Size and Volume Forecast by Type
11.7.1. Low Purity(Below 97%)
11.7.2. Purity(Above 97% and Below 99%)
11.7.3. High Purity(Above 99%)
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Atractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Kainic Acid Demand Share, 2019-2026
12. Asia Pacific Kainic Acid Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Kainic Acid Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Kainic Acid Market Size and Volume Forecast by Application
12.4.1. Epilepsy Treatment
12.4.2. Neurological Research
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Kainic Acid Market Size and Volume Forecast by Type
12.7.1. Low Purity(Below 97%)
12.7.2. Purity(Above 97% and Below 99%)
12.7.3. High Purity(Above 99%)
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Kainic Acid Demand Share, 2019-2026
13. Middle East & Africa Kainic Acid Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Kainic Acid Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Kainic Acid Market Size and Volume Forecast by Application
13.4.1. Epilepsy Treatment
13.4.2. Neurological Research
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Kainic Acid Market Size and Volume Forecast by Type
13.7.1. Low Purity(Below 97%)
13.7.2. Purity(Above 97% and Below 99%)
13.7.3. High Purity(Above 99%)
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Kainic Acid Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Kainic Acid Market: Market Share Analysis
14.2. Kainic Acid Distributors and Customers
14.3. Kainic Acid Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. R&D Systems
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abcam
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Stemgent
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cayman Chemical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Santa Cruz Biotechnology
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. STEMCELL Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Alfa Chemistry
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Anward
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Race Chemical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Glentham Life Sciences
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. AbMole Bioscience
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Aurum Pharmatech LLC
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Tocris Bioscience
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Enzo Life Sciences
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook